WHO Childhood Cancer Data Reveal Survival Gaps Across 194 Countries and Age Groups

Adolescents aged 15–19 experience a wider survival gap than children aged 0–14, with the sharpest divide found in low- and middle-income countries.

A child's chances of surviving cancer still depend heavily on where they live, despite treatments that can save many young lives when diagnosis and care arrive in time. The World Health Organization's Global Initiative for Childhood Cancer (GICC) has released the first comparable five-year survival estimates for lymphoid leukaemia among children and adolescents across all 194 WHO Member States. The complete dataset, available through the WHO Global Health Observatory, gives governments a shared starting point for measuring progress, comparing outcomes and identifying communities where investment is most urgently needed.

A clearer picture of survival and unequal access to care

The findings underpin WHO's May 2026 report, Measuring survival, driving change: advancing equity through the WHO Global Initiative for Childhood Cancer, which documents improving survival alongside deep geographical and age-related inequalities. Using a common methodology across countries makes comparisons more consistent, although these are estimates rather than complete counts of every child's experience. The dataset specifically measures lymphoid leukaemia survival, providing a baseline to help track progress towards the broader GICC target of at least 60% childhood cancer survival globally by 2030.

Around 400,000 children and adolescents develop cancer each year, and access to effective treatment can make an enormous difference to their chances of recovery. The release describes survival reaching 80–90% in high-income countries, compared with levels closer to 40% in settings with weaker health systems. WHO's Western Pacific and European Regions record some of the highest estimated survival levels; the African Region and parts of the Eastern Mediterranean Region face persistent difficulties with timely diagnosis, essential medicines and high-quality care. For families, those gaps can mean a treatable illness becomes much harder to survive because the services their child needs are unavailable or difficult to reach.

Teenagers face additional barriers, and many cases remain invisible

Adolescents aged 15–19 experience a wider survival gap than children aged 0–14, with the sharpest divide found in low- and middle-income countries. Delayed diagnosis, gaps between paediatric and adult services, and limited evidence on adolescent cancer care can leave teenagers without care suited to their needs. The types of cancer affecting adolescents differ from those seen in younger children, making age-appropriate treatment pathways an essential part of improving survival rather than assuming that services designed for younger patients will meet every teenager's needs.

Missing information makes the scale of the problem harder to understand, with nearly 80% of the world's population outside the coverage of population-based cancer registries and up to 43% of childhood cancer cases going undiagnosed and untreated in some regions. Cancer registries help health services understand who develops cancer and what happens after diagnosis, giving planners evidence to improve care. WHO's International Agency for Research on Cancer and the childhood cancer work of the Global Initiative for Cancer Registry Development, ChildGICR, have trained 125 health professionals across 27 territories to strengthen registration and data quality.

Political promises need investment that reaches children

Dr Roberta Ortiz, Childhood Cancer Medical Officer in WHO's Cancer Programme, describes childhood cancer survival as a clear indicator of health-system performance, stressing that universal health coverage inclusive of childhood cancer can dramatically improve outcomes. WHO presents investment in childhood cancer care as a "best buy" for tackling noncommunicable diseases, including cancer, with an economic case that reinforces the human need for accessible treatment. Coordinated national planning, reliable medicines and stronger services are central to turning that investment into better survival.

The 60% survival target was included in the 2025 political declaration of the United Nations General Assembly's high-level meeting on noncommunicable diseases, committing to greater international backing. Sustained political support and strategic investment could put the GICC ambition of saving one million additional lives by 2030 within reach, giving more children and teenagers the chance to grow up.